Incidence of chronic kidney disease hospitalisations and mortality in Espírito Santo between 1996 to 2017


Autoři: Wesley de Souza aff001;  Luiz Carlos de Abreu aff001;  Leonardo Gomes da Silva aff002;  Italla Maria Pinheiro Bezerra aff001
Působiště autorů: Programa de Mestrado em Política Públicas e Desenvolvimento Local, Escola Superior de Ciências da Santa Casa de Misericórdia de Vitória (EMESCAM), Vitória, Espírito Santo, Brazil aff001;  Laboratório de Escrita Científica, Escola Superior de Ciências da Santa Casa de Misericórdia de Vitória (EMESCAM), Vitória, Espírito Santo, Brazil aff002;  Laboratório de Delineamento de Estudos e Escrita Científica, Centro Universitário Saúde ABC (CUSABC), Santo André, São Paulo, Brazil aff003;  Graduate Entry Medical School, University of Limerick, Limerick, Ireland aff004;  Programa de Mestrado em Ciências da Saúde da Amazônia, Bolsista CAPES Brasil, Universidade Federal do Acre, Rio Branco, Acre, Brazil aff005
Vyšlo v časopise: PLoS ONE 14(11)
Kategorie: Research Article
doi: 10.1371/journal.pone.0224889

Souhrn

Introduction

Chronic kidney disease (CKD) has a set of clinical and laboratory abnormalities where renal function loss is noted. The high prevalence of comorbidity of people living with CKD, its economic impact and its prognosis have made it a public health problem, justifying the need to implement preventive measures.

Objective

To analyse the mortality and incidence of hospital admissions for CKD.

Methods

Ecological study with a time series design using secondary microdata of deaths and hospital admissions from patients with CKD from 1996 to 2017 in the State of Espírito Santo, Brazil.

Results

The average mortality rate of CKD during the studied years was 2.92 per 100,000 inhabitants per year. During this period global mortality was a stationary phenomenon. In women, the trend of mortality from 2005 on increased 7,87% per year. Between 2008 and 2017, the average incidence hospital admissions due to CKD per year was 45.76 per 100,000 inhabitants. It was observed that the overall hospital admission increased by the equivalent of 6.23% per year. More than a half of mortality and hospitalisations correspond to male patients over 50 years of age. In terms of mortality, 32.99% corresponded to Caucasian patients, while 35.13% of hospitalisations were mixed race.

Conclusion

We found that age and gender are factors associated with deaths and hospitalisations for chronic kidney disease. While hospitalisation increases 6.23% per year, global mortality remains stationary. However, from 2005 onwards a trend towards increasing of 7.87%/annual in mortality was observed in women.

Klíčová slova:

Age groups – Brazil – Death rates – Hospitals – Chronic kidney disease – Kidneys – Medical dialysis


Zdroje

1. World Health Organization. Global burden of disease study. WHO. World Health Organization; 2003; Available: http://www3.who.int/whosis/menu.cfm?path=evidence,burden&language=english

2. Bernardi Cesarino C, Peruche Borges P, de Cássia Helú Mendonça Ribeiro R, Fávaro Ribeiro D, Kusumota L. Assessment of cardiovascular risk in patients with chronic kidney disease according to Framingham’s criteria Avaliação do risco cardiovascular de pacientes renais crônicos segundo critérios de Framingham [Internet]. Acta Paul Enferm. 2013. Available: http://www.scielo.br/pdf/ape/v26n1/en_16.pdf

3. Gouveia DS e S, Bignelli AT, Hokazono SR, Danucalov I, Siemens TA, Meyer F, et al. Analysis of economic impact among modalities of renal replacement therapy. J Bras Nefrol. Sociedade Brasileira de Nefrologia; 2017;39: 162–171. doi: 10.5935/0101-2800.20170019 28489179

4. Domingos MAM, Goulart AC, Lotufo PA, Benseñor IJM, Titan SM de O. Chronic kidney disease—determinants of progression and cardiovascular risk. PROGREDIR cohort study: design and methods. Sao Paulo Med J. 2017; doi: 10.1590/1516-3180.2016.0272261116 28443950

5. James MT, Hemmelgarn BR, Tonelli M. Early recognition and prevention of chronic kidney disease. The Lancet. 2010. doi: 10.1016/S0140-6736(09)62004-3

6. Terra, FS. Evaluation of the quality of life of end-stage renal patients submitted to hemodialysis and their adhesion to daily pharmacologic treatment. M.Sc. Thesis, UNIFENAS, 2007. Available from: http://tede2.unifenas.br:8080/jspui/handle/jspui/66

7. Obrador GT, Pereira B. "Epidemiology of chronic kidney disease." Retrieved 7.15 (2014): 2014.

8. Sociedade Brasileira de Nefrologia (SBN). Censo 2016. 2017.

9. Sociedade Brasileira de Nefrologia. 2014; 6000.

10. Garcia-Garcia G, Jha V, Li PKT, Couser WG, Erk T, Zakharova E, et al. CKD in disadvantaged populations. Am J Nephrol. 2015; doi: 10.1159/000369843 25766137

11. Magalhães FG, Monteiro Goulart RM. Chronic kidney disease and its treatment in the elderly: an integrative review. Rev BRas GeRiatR GeRontol. 2015;18: 679–692. doi: 10.1590/1809-9823.2015.14132

12. Brasil M da S. Diretrizes Clínicas para o cuidado ao paciente com doença renal crônica no Sistema Único de Saúde. Ministério Da Saúde. 2014. doi: 10.1007/s13398-014-0173-7.2

13. Sesso R, Lopes AA, Thomé FS, Bevilacqua JL. Relatório do Censo Brasileiro de Diálise, 2008 Brazilian Dialysis Census Report, 2008. Nefrologia. 2008;

14. Silva JL. Suicídios invisibilizados: Investigação dos óbitos de adolescentes com intencionalidade indeterminada. Tese Doutorado. 2017;

15. Zetola VH, Novak EM, Camargo CH, Carraro HJ, Coral P, Muzzio JA, et al. [Stroke in young adults: analysis of 164 patients]. Arq Neuropsiquiatr. 2001;

16. Brasil. Ministério da Saúde (MS). Cadastro Nacional de Estabelecimentos de Saúde (CNES). DataSUS. 2017. doi: 10.1007/s00586-013-2893-3 LK - http://bc-primo.hosted.exlibrisgroup.com/openurl/BCL/services_page?&sid=EMBASE&issn=14320932&id=doi:10.1007%2Fs00586-013-2893-3&atitle=Antibiotics+a+cure+for+back+pain%2C+a+false+dawn+or+a+new+era%3F&stitle=Eur.+Spine+J.&title=European+Spine+Journal&volume=22&issue=8&spage=1694&epage=1697&aulast=O%27Dowd&aufirst=John&auinit=J.&aufull=O%27Dowd+J.&coden=ESJOE&isbn=&pages=1694-1697&date=2013&auinit1=J&auinitm=

17. IBGE. Censo Demográfico 2010: Características gerais da população, religião e pessoas com deficiencia, segundo a situação do domicílio e grupos de idade. In: Brasil. 2010.

18. Ahmad OB, Boschi-pinto C, Lopez AD, Murray CJ, Lozano R, Mie I. AGE STANDARDIZATION OF RATES: A NEW WHO STANDARD GPE Discussion Paper Series: No. 31 EIP / GPE / EBD World Health Organization 2001. World Heal Organ. 2001; doi: 10.1161/HYPERTENSIONAHA.114.04394

19. Antunes JLF, Cardoso MRA. Uso da análise de séries temporais em estudos epidemiológicos. Epidemiol e Serviços Saúde. 2015; doi: 10.5123/S1679-49742015000300024

20. Herrera-Añazco P, Benites-Zapata V, Hernandez A V., Mezones-Holguin E, Silveira-Chau M. Mortality in patients with chronic kidney disease undergoing hemodialysis in a public hospital of Peru. J Bras Nefrol. 2015; doi: 10.5935/0101-2800.20150031 26154639

21. Jain P, Calvert M, Cockwell P, McManus RJ. The need for improved identification and accurate classification of stages 3–5 chronic kidney disease in primary care: Retrospective cohort study. PLoS One. 2014; doi: 10.1371/journal.pone.0100831 25115813

22. Instituto Brasileiro de Geografia e Estatística. 2017.

23. Scialla JJ, Appel LJ, Astor BC, Miller ER, Beddhu S, Woodward M, et al. Net endogenous acid production is associated with a faster decline in GFR in African Americans. Kidney Int. 2012; doi: 10.1038/ki.2012.82 22475819

24. Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS, et al. Global prevalence of chronic kidney disease—A systematic review and meta-analysis. PLoS ONE. 2016. doi: 10.1371/journal.pone.0158765 27383068

25. Goncalves GMR, Da Silva EN. Cost of chronic kidney disease attributable to diabetes from the perspective of the Brazilian Unified Health System. PLoS ONE. 2018. doi: 10.1371/journal.pone.0203992 30273345

26. Shen Y, Cai R, Sun J, Dong X, Huang R, Tian S, et al. Diabetes mellitus as a risk factor for incident chronic kidney disease and end-stage renal disease in women compared with men: a systematic review and meta-analysis. Endocrine. 2017; doi: 10.1007/s12020-016-1014-6 27477292

27. Narres M, Claessen H, Droste S, Kvitkina T, Koch M, Kuss O, et al. The incidence of end-stage renal disease in the diabetic (compared to the non-diabetic) population: A systematic review. PLoS ONE. 2016. doi: 10.1371/journal.pone.0147329 26812415

28. Pinheiro RS, Viacava F, Travassos C, Brito A dos S. Gênero, morbidade, acesso e utilização de serviços de saúde no Brasil. Cien Saude Colet. 2002; doi: 10.1590/S1413-81232002000400007

29. Goes EF, Nascimento ER do. Mulheres negras e brancas e os níveis de acesso aos serviços preventivos de saúde: uma análise sobre as desigualdades. Saúde em Debate. 2013; doi: 10.1590/S0103-11042013000400004

30. Hemke AC, Heemskerk MB, Van Diepen M, Weimar W, Dekker FW, Hoitsma AJ. Survival prognosis after the start of a renal replacement therapy in the Netherlands: A retrospective cohort study. BMC Nephrol. 2013; doi: 10.1186/1471-2369-14-258 24256551

31. Magalhaes LP, Dos Reis LM, Graciolli FG, Pereira BJ, De Oliveira RB, De Souza AAL, et al. Predictive factors of one-year mortality in a cohort of patients undergoing urgent-start Hemodialysis. PLoS One. 2017; doi: 10.1371/journal.pone.0167895 28045952

32. Kao CC, Yang JY, Chen L, Chao C Ter, Peng Y Sen, Chiang CK, et al. Factors associated with poor outcomes of continuous renal replacement therapy. PLoS One. 2017; doi: 10.1371/journal.pone.0177759 28542272

33. Kihal-Talantikite W, Deguen S, Padilla C, Siebert M, Couchoud C, Vigneau C, et al. Spatial distribution of end-stage renal disease (ESRD) and social inequalities in mixed urban and rural areas: A study in the Bretagne administrative region of France. Clin Kidney J. 2015; doi: 10.1093/ckj/sfu131 25713704

34. Marinovich S, Lavorato C, Rosa-Diez G, Bisigniano L, Fernández V, Hansen-Krogh D. The lack of income is associated with reduced survival in chronic haemodialysis. Nefrologia. 2012; doi: 10.3265/Nefrologia.pre2011.Nov.11110 22294006

35. Green JA, Cavanaugh KL. Understanding the influence of educational attainment on kidney health and opportunities for improved care. Advances in Chronic Kidney Disease. 2015. doi: 10.1053/j.ackd.2014.07.004 25573509

36. Registro Brasileiro de Transplantes. Dimensionamento dos Transplantes no Brasil e em cada estado (2018). Veículo oficial da Associação Brasileira de Transplante de Órgãos (ABTO). 2018.

37. De Vries EF, Rabelink TJ, Van Den Hout WB. Modelling the Cost-Effectiveness of Delaying End-Stage Renal Disease. Nephron. 2016; doi: 10.1159/000446548 27270045

38. Xue-Juan W, Hao W, Cai-Ying G, Xin-Ying L, Hong-Yan J, Li W, et al. Impact of an intelligent chronic disease management system on patients with type 2 diabetes mellitus in a Beijing community. BMC Health Serv Res. 2018; doi: 10.1186/s12913-018-3610-z 30373577

39. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: Global dimension and perspectives. The Lancet. 2013. http://dx.doi.org/10.1016/S0140-6736(13)60687-X

40. Tonelli M, Agarwal S, Cass A, Garcia Garcia G, Jha V, Naicker S, et al. How to advocate for the inclusion of chronic kidney disease in a national noncommunicable chronic disease program. Kidney International. 2014. doi: 10.1038/ki.2012.488 23407433

41. Maria I, Bezerra P. Translational medicine and its contribution to public health Medicina translacional e as contribuições para saúde pública. J Hum Growth Dev J Hum Growth Dev. 2017; doi: 10.7322/jhgd.123189

42. de Abreu LC, Pereira VX, Silva RPM, Macedo H, Bezerra IMP. The right to scientific information: One of the main elements of the unified health system. Journal of Human Growth and Development. 2017. doi: 10.7322/jhgd.141485


Článek vyšel v časopise

PLOS One


2019 Číslo 11